CDK7 and leukemia: Consistent with the results from pharmacological inhibition using BETi and/or THZ1, we found that only the dual knockdown of BRD4 and CDK7, but not single-knockdown, substantially inhibited the growth of BETi-resistant leukemia cells (red/purple curves; Fig. 2f, g).